Univariable survival analyses according to molecular markers (a,b), smoking habits (c), and histotype (d). (a) Outcome (disease-specific survival) of IDH2-mutated (n = 5), INI1 negative (n = 9), and IDH2/INI1 wild-type (n = 37) cases; (b) Outcome of IDH2-mutated, INI-1 negative or LINE-1 hypermethylated cases combined together (presence of at least one variable, n = 27) versus wild-type or LINE-1 < 70% cases (n = 24); (c) outcome of smokers (n = 22) versus non-smokers (n = 29); (d) disease-specific survival analysis comparing the three histotypes: NEC (neuroendocrine carcinomas), SCC (squamocellular carcinoma), and SNUC (sinonasal undifferentiated carcinoma).